Table 4.
Gene | Mutationa | Observed phenotypeb | Reported phenotypeb | Reference |
---|---|---|---|---|
rplD/L4 | E13Q, E30Q, V88I, G98A, A128S, S130E | See notes c and d | No resistance | 56 |
E30K | Q-D | M | 54 | |
S112L | See note d | This study | ||
Q67R + R72G | Q-D LZD | LZD | 14 | |
69GTG71 to TPS | MSB | ML, M, MSB | 17, 50, 56 | |
63KPWRQKTGTGRAR74 | M | This study | ||
63KPWRQKGKGTGRAR74 | Q-D | ERY-I AZI-R | 37 e | |
63KPWRQKGSQKGTGRAR74 | M Q-D | This study | ||
63KPWRPWRQKGTGRAR74 | Q-D | This study | ||
rplV/L22 | R103C | M Q-D | This study | |
102KRTAHITRTAHIVA110 | M Q-D | M Q-D | 29 | |
102KRTAHITRTAHITVA110 | M Q-D | ML, M, M Q-D | 17, 40 | |
102KRTAHITKRTAHIVA110 | M Q-D | M Q-D | 6 | |
102KRTAHITKRTAHITVA110 | M Q-D | This study | ||
102KRTAHITVRTAHITVA110 | M Q-D | This study | ||
T85P | See note 4 | This study | ||
85PMKRFRPPMKRFRPRAK94 | M Q-D | This study | ||
85TMKRFRPRASFRPRAK94 | M Q-D | This study | ||
76SEAFANEGPTIAFANEGPTM86 | M Q-D | This study | ||
23s d. V | A2061G (2059 in Escherichia coli) | M, MLSB | ML, MLSB, MSB | 16, 49, 50, 54 |
C2613G (2611 in E. coli) | M Q-D | M, M Q-D | 16, 49, 52 | |
A2060C (2058 in E. coli) | MLSB | ML, M | 33, 42, 52e |
Insertions are underlined.
“Observed phenotype” refers to this study, while “Reported phenotype” refers to phenotypes observed in previous reports.
These changes were found in combination with the 69GTG71 to TPS substitution.
Only found in combination with other changes, its role in resistance is unclear.
These reports pertain to other bacterial species. Our study is the first to report these changes in Streptococcus pneumoniae.
AZI, azithromycin; ERY, erythromycin; LZD, linezolid; L, lincosamides; M, macrolides; SB, streptogramin B; Q-D, quinupristin–dalfopristin (Synercid).